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and no instances of prolonged mechanical ventilation or tra-
cheostomy. Thus, these patients would also seem to be good
candidates for a hybrid approach when feasible.
In summary, ‘‘hybrid’’ aortic debranching with custom
fabricated Dacron branch grafts with a single inflow source
combinedwith endovascular aneurysmexclusion, a technique
that avoids the need for CPB and aortic crossclamping, ap-
pears to be a safe alternative to conventional open repair
for thoracoabdominal and aortic arch aneurysms. This
technique may be ideally suited to patients with significant
comorbidity or prior open aortic surgery. Longer term fol-
low-up is needed to determine the durability of this ap-
proach.18 However, given that the long-term survival of
patients undergoing repair of degenerative thoracic and thor-
acoabdominal aneurysms is limited (eg, approximately 30%
survival at 10 years after open TAAA repair,19,20 this latter
concern is unlikely to be an issue in the majority of these
patients.
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DrD. CraigMiller (Stanford, Calif). I would like to welcome Chad
Hughes to the Western Thoracic. If you keep doing this for 15 years
in a row, like Walter Wolfe, we will make you an honorary member.
It is nice to see the work from Duke come out west.
I want to compliment you for doing it right. You have a combined
cardiothoracic and vascular surgical team in which the cardiotho-
racic surgeon is involved at the first step, the decision-making
step, should anything be done regardless of whether it is endovascu-
lar or open. That is crucial, and I think that is the paramount differ-
ence between the indications we have seen today, which none of us
would disagree with, and those we saw yesterday, in which a periph-
eral vascular surgeon is making that decision in a vacuum and per-
haps patients are not being well served. You have done it right, and
your results, albeit short term and small in number, are absolutely
spectacular given the protoplasm you were dealing with.
My only question involves the grafts. They were Vascutek
grafts, and I am still unclear whether they were custom fabricated
for you or whether you made them at the back table, which is
what we do. I would hope, since many of them are long tortuous
small-caliber small-flow grafts, that these were Gelsoft or knitted
grafts and not Gelweave or a woven graft or the Microvel Double
Velour Hemashield (Boston Scientific Corporation, Natick, Mass)-
knitted compared with the woven grafts we have all learned that with
low flow, a knitted graft probably is going to have better patency.
DrHughes.DrMiller, thank you very much for your comments.
I hope we can get papers on the program 15 years in a row and get
out here like Dr Wolfe.
I agree 100% with your first comment regarding the team ap-
proach. I think that is key. I learned that from Joe Bavaria at the Uni-
versity of Pennsylvania, where they have a very integrated program
with their vascular surgeons. We have modeled that at Duke, and all
these patients are reviewed jointly by me and the vascular surgeons.
We each bring something separate to the table, the vascular surgeons
especially with their endovascular techniques, which we are now
learning. I think we are where the vascular surgeons were maybe
5 to 7 years ago, when they were learning from the radiologists.racic and Cardiovascular Surgery c Volume 136, Number 1 27
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lar surgeons. I believe over time more and more cardiac surgeons
will be involved in these kinds of procedures.
With regard to the grafts, they are Gelweave and maybe we
should switch toGelsoft grafts per your recommendation. In the early
patients in the series, we used the 3-vessel grafts that were originally
made for open arch surgery.We implanted both head vessels, and for
the belly Vascutek had a graft that had 4 side branches that we were
using. We now have had Vascutek design a special graft for the arch
that has the integrated limb and has only 2 distal side branches for the
innominate and the carotid. They have also now made us a custom
graft for the belly that has one branch that goes this way for the supe-
rior mesenteric artery, one this way for the renal, one for the celiac,
and then a longer one for the right renal with an antegrade limb. I
think if they can make the graft for you, it is a little bit better.
Dr Miller. It takes away the fun for the junior resident, though,
who no longer gets to put the grafts together.
We still go for the left subclavian if we are doing this, and I think
for the audience we should be doing this more. Number one, the an-
tegrade approach for stent graft deployment is much safer. We have
not done a lot, but every time we do it we kick ourselves for flogging
from the groin and having all those access problems that can lead to
real trouble. I think we should be doing this more, but if you are there
and you are going to bypass 2 vessels, why not bypass all 3? We
have been burned, as has everybody, with a cavalier approach to
covering the left subclavian artery. Even if you know the right
vertebral is the dominant vessel, it is not just the arm claudication
ischemic symptoms, but it is the posterior fossa basilar strokes.
They are unpredictable. I think almost everybody will now be
turning the corner into a more aggressive left subclavian revascular-
ization, whether it be a supraclavicular, carotid–subclavian transpo-
sition, or something else. You are there, and it is sitting right there.
Granted, it is deep, but you can get to it, and why not make a quadru-
ple prosthesis? Do all 3 arch vessels and your fourth limb for the
antegraft stent graft deployment, which takes 5 or 10 minutes.
Isn’t it amazing when you are close to it how easy it is compared
with when you are doing it from a long distance down below?
The pump standby that you mentioned is key. As recently as 2
weeks ago, one of these end-to-side proximal anastomoses dehisced28 The Journal of Thoracic and Cardiovascular Surgery c Julyoff the ascending aorta right before our eyes, and the patient needed
the pump. It is absolutely essential, and it is going to be more impor-
tant as we move to the hybrid operating rooms, which are a little
more crowded. There is better imaging, but the pump driver and
pump must be available, because you can get into trouble. It is
also perhaps easier, warm beating partial bypass, especially if the
ascending aorta to which you are sewing is thin and friable.
DrMatthew Slater (Portland, Ore).Dr Miller stole my thunder
because we have a limited experience, but we have been anastomos-
ing to the left subclavian to obviate all the issues that come up.
My actual question is technical. In the angiography suite, the im-
aging equipment at our institution is better and so sizing is a little
more straightforward. I have found some difficulty in sizing with
fluoroscopy in the operating room. Do you have any technical hints
for using single-plane fluororoscopy in the operating room that have
been useful in the arch, which is a hard place to size?
Dr Hughes. Are you talking about sizing the stent grafts?
Dr Slater.Yes, sizing the stent grafts and positioning them in the
arch with somewhat suboptimal fluoroscopy as opposed to a fluoros-
copy suite.
Dr Hughes. I think the majority of our stent graft sizing infor-
mation comes from our preoperative imaging with a true 90 flow
lumen measurement. We use the Tera Recon system, which I
can’t say enough about. Either the IVUS (Volcano Corp, Rancho
Cordova, Calif) system or the M25S can provide very accurate
arch measurements, at least in my experience. If we have any ques-
tion we will just use IVUS, with the caveat that with the IVUS sys-
tem catheter may not be exactly in the center of the aorta. It may not
be providing a true 90 flow lumen measurement with the IVUS
catheter, but if I have any questions about sizing based on my CT
scan, I will use IVUS as kind of a tie breaker to help decide stent
graft size. On those arch grafts, we put radiographic markers around
where the proximal anastomosis comes off, which are very easily
seen during fluoroscopy. Thus, we know not to go past this point
with the stent graft. We do not have fixed imaging yet either. We
have the 9-900 OEC C-arm (Bighorn Biomedical Services, Inc,
Moorcroft, Wyo), which is acceptable but not ideal. We have
been able to use that in all these cases with pretty much no problem,
even in the big patients.2008
